Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma

BACKGROUND: Angiogenesis is essential for tumour growth and metastasis. There are conflicting reports as to whether microvessel density (MVD) using the endothelial marker CD105 (cluster of differentiation molecule 105) in clear-cell renal cell carcinomas (ccRCC) is associated with prognosis. Recentl...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Saroufim, A, Messai, Y, Hasmim, M, Rioux, N, Iacovelli, R, Verhoest, G, Bensalah, K, Patard, J-J, Albiges, L, Azzarone, B, Escudier, B, Chouaib, S
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Molecular Diagnostics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3974088/
https://ncbi.nlm.nih.gov/pubmed/24594997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.71
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items